These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 75140)

  • 1. [The role of antithrombin in disorders of hemostasis].
    Róka L; Bleyl H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(6):707-18. PubMed ID: 75140
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombin inhibiting action of heparin.
    Abildgaard U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):408-16. PubMed ID: 4121334
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
    Seegers WH
    Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the heparin-neutralizing effect of plasma in disorders of hemostasis (clinical use of the "heparin-thrombin coagulation time")].
    Misz M; Boda Z; Rák K
    Orv Hetil; 1977 Sep; 118(37):2195-9. PubMed ID: 917513
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modern concepts of the hemostatic and fibrinolytic systems].
    Andreenko GV
    Klin Med (Mosk); 1974 Apr; 52(4):13-23. PubMed ID: 4282102
    [No Abstract]   [Full Text] [Related]  

  • 6. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
    Raby C
    Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
    Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin cofactor and plasma antithrombin in relation to the mechanism of inactivation of thrombin by heparin.
    Porter P; Porter MC; Shanberge JN
    Clin Chim Acta; 1967 Aug; 17(2):189-200. PubMed ID: 6035543
    [No Abstract]   [Full Text] [Related]  

  • 9. The progressive antithrombin (antithrombin-III, heparin-cofactor).
    Pálos LA
    Haematologia (Budap); 1974; 8(1-4):455-9. PubMed ID: 4461431
    [No Abstract]   [Full Text] [Related]  

  • 10. The hemostatic mechanism and its defects.
    Macfarlane RG
    Int Rev Exp Pathol; 1968; 6():55-133. PubMed ID: 4884086
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of natural coagulation inhibitors in hemostasis.
    Brandt JT
    Clin Lab Med; 1984 Jun; 4(2):245-84. PubMed ID: 6094091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin and antithrombin: their opposing functions in blood coagulation.
    Grannis GF; Kazal LA
    Thromb Diath Haemorrh; 1966 Dec; 16(3):497-506. PubMed ID: 5996671
    [No Abstract]   [Full Text] [Related]  

  • 13. New antithrombin-based anticoagulants.
    Desai UR
    Med Res Rev; 2004 Mar; 24(2):151-81. PubMed ID: 14705167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of hypercoagulability in venous and arterial thrombosis.
    Wessler S
    Cardiovasc Clin; 1971; 3(1):1-16. PubMed ID: 4944368
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor V and VIII activation "in vivo" during bleeding. Evidence of thrombin formation at the early stage of hemostasis.
    Jensen AH; Beguin S; Josso F
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():6-10. PubMed ID: 796811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombogenic abnormalities of hemostasis. Practical implications].
    Vergoz D
    Phlebologie; 1985; 38(3):415-6. PubMed ID: 3840597
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin neutralizing activity (HNA) and antithrombin III in coronary artery disease.
    Cella G; Russo R
    Thromb Haemost; 1977 Oct; 38(3):696-700. PubMed ID: 579515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic of blood coagulation].
    Barthels M
    Hamostaseologie; 2008 Dec; 28(5):320-34. PubMed ID: 19132163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombin III and its role in normal and pathological hemostasis].
    Bŭchvarova V; Doĭchinov A; Angelova N
    Vutr Boles; 1981; 20(6):34-8. PubMed ID: 7039127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant effect of sulphated poly/vinyl alcohol-acrylic acid/copolymers.
    Machovich R; Nagy M; Györgyi-Edelényi J; Csomor K; Horváth I
    Thromb Haemost; 1986 Dec; 56(3):397-400. PubMed ID: 2951893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.